S'abonner

R-loops cause genomic instability in T helper lymphocytes from patients with Wiskott-Aldrich syndrome - 04/07/18

Doi : 10.1016/j.jaci.2017.11.023 
Koustav Sarkar, PhD a, , , Seong-Su Han, PhD a, , Kuo-Kuang Wen, PhD a, , Hans D. Ochs, MD b, Loïc Dupré, PhD c, d, e, f, g, Michael M. Seidman, PhD h, Yatin M. Vyas, MD a,
a Division of Pediatric Hematology-Oncology, Carver College of Medicine and the University of Iowa Stead Family Children's Hospital, Iowa City, Md 
b Center for Immunity and Immunotherapies, Seattle Children's Research Institute, University of Washington, Seattle, Md 
c INSERM, UMR1043, Centre de Physiopathologie de Toulouse Purpan, Toulouse, Md 
d Université Toulouse III Paul-Sabatier, Toulouse, Md 
e CNRS, UMR5282, Toulouse, Md 
f Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Md 
g CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Md 
h Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health (NIH), NIH Biomedical Research Center, Baltimore, Md 

Corresponding author: Yatin M. Vyas, MD, Division of Pediatric Hematology-Oncology, University of Iowa Stead Family Children's Hospital, The University of Iowa Carver College of Medicine, Iowa City, IA 52242.Division of Pediatric Hematology-OncologyUniversity of Iowa Stead Family Children's HospitalThe University of Iowa Carver College of MedicineIowa CityIA52242

Abstract

Background

Wiskott-Aldrich syndrome (WAS), X-linked thrombocytopenia (XLT), and X-linked neutropenia, which are caused by WAS mutations affecting Wiskott-Aldrich syndrome protein (WASp) expression or activity, manifest in immunodeficiency, autoimmunity, genomic instability, and lymphoid and other cancers. WASp supports filamentous actin formation in the cytoplasm and gene transcription in the nucleus. Although the genetic basis for XLT/WAS has been clarified, the relationships between mutant forms of WASp and the diverse features of these disorders remain ill-defined.

Objective

We sought to define how dysfunctional gene transcription is causally linked to the degree of TH cell deficiency and genomic instability in the XLT/WAS clinical spectrum.

Methods

In human TH1- or TH2-skewing cell culture systems, cotranscriptional R-loops (RNA/DNA duplex and displaced single-stranded DNA) and DNA double-strand breaks (DSBs) were monitored in multiple samples from patients with XLT and WAS and in normal T cells depleted of WASp.

Results

WASp deficiency provokes increased R-loops and R-loop–mediated DSBs in TH1 cells relative to TH2 cells. Mechanistically, chromatin occupancy of serine 2-unphosphorylated RNA polymerase II is increased, and that of topoisomerase 1, an R-loop preventing factor, is decreased at R-loop–enriched regions of IFNG and TBX21 (TH1 genes) in TH1 cells. These aberrations accompany increased unspliced (intron-retained) and decreased spliced mRNA of IFNG and TBX21 but not IL13 (TH2 gene). Significantly, increased cellular load of R-loops and DSBs, which are normalized on RNaseH1-mediated suppression of ectopic R-loops, inversely correlates with disease severity scores.

Conclusion

Transcriptional R-loop imbalance is a novel molecular defect causative in TH1 immunodeficiency and genomic instability in patients with WAS. The study proposes that cellular R-loop load could be used as a potential biomarker for monitoring symptom severity and prognostic outcome in the XLT-WAS clinical spectrum and could be targeted therapeutically.

Le texte complet de cet article est disponible en PDF.

Graphical abstract




Le texte complet de cet article est disponible en PDF.

Key words : Primary immunodeficiency, Wiskott-Aldrich syndrome, X-linked thrombocytopenia, TH1/TH2 differentiation, R-loops, DNA damage, genomic instability

Abbreviations used : ChIP, DDR, DRB, DRIP, DSB, EU, GFP, IR+, KD, KO, MNase, MS, NF-κB, qPCR, RNAP2, shRNA, S2P, S2unP, S5P, TOP, WAS, WASp, WKO or WKD, WT, XLT


Plan


 Supported by National Institutes of Health (NIH) grant R01AI084957 (to Y.M.V.), the Intramural Research Program of the NIH, the National Institute on Aging grant Z01AG000746-08 (to M.M.S.), and the DeJoria Wiskott-Aldrich Research Fund (to H.D.O.).
 Disclosure of potential conflict of interest: Y. M. Vyas's institution received grant R01 award from the National Institute of Allergy and Infectious Diseases for this work. The rest of the authors declare that they have no relevant conflicts of interest.


© 2017  American Academy of Allergy, Asthma & Immunology. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 142 - N° 1

P. 219-234 - juillet 2018 Retour au numéro
Article précédent Article précédent
  • Orosomucoid-like 3 (ORMDL3) upregulates airway smooth muscle proliferation, contraction, and Ca2+ oscillations in asthma
  • Jun Chen, Marina Miller, Hirotoshi Unno, Peter Rosenthal, Michael J. Sanderson, David H. Broide
| Article suivant Article suivant
  • Transfer of gene-corrected T cells corrects humoral and cytotoxic defects in patients with X-linked lymphoproliferative disease
  • Neelam Panchal, Ben Houghton, Begona Diez, Sujal Ghosh, Ida Ricciardelli, Adrian J. Thrasher, H. Bobby Gaspar, Claire Booth

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.